15 December 2016

Tom Nijenhuis, nephrologist and researcher, theme Renal disorders and colleagues demonstrated how sildenafil (Viagra) can prevent damage to the glomerular filter in the kidney. Damage to the glomerular filter occurs in patients with rare primary glomerular diseases, or in patients with secondary glomerular injury due to more common diseases like diabetes, hypertension or vascular injury, which all lead to chronic kidney injury.

Previous research showed that increased activity or overexpression of the Ca2+-permeable ion channel TRPC6 induces deleterious downstream signaling cascades in glomerular podocytes, identifying TRPC6-mediated signaling as a putative treatment target in glomerular disease.

Funded by a Dutch Kidney Foundation- Kolff Career Stimulation grant, and in collaboration with researchers from the Departments of Nephrology, Physiology and Pathology, together with international collaborators, Nijenhuis now identified a TRPC6 inhibitory signaling pathway in the podocyte. This pathway could be activated by sildenafil, thereby preventing glomerular injury in animals models for focal segmental glomerulosclerosis and diabetic nephropathy. Since sildenafil is approved for clinical use and is therefore available for treatment in humans, this study warrants further clinical studies into its beneficial effects in glomerular disease.

The results were recently published in the high-ranking Journal of the American Society of Nephrology.

 

Related news items


Ignacio Malagon, first professor of Pediatric Anaesthesiology in the Netherlands

21 January 2019

Ignacio Malagon has been appointed professor of Pediatric Anaesthesiology at Radboud University / Radboud university medical center with effect from 1 January 2019. He is the first professor in this field in the Netherlands.

read more

Thomas Maal appointed full professor of 3D Technology in Healthcare

7 January 2019

3D technology leads to better care and lower costs.

read more

Quickly detecting actual heart attacks prevents unnecessary hospital visits Research by Radboud university medical center improves efficacy and reduces cost of cardiac care

4 January 2019

Many patients who suffer from chest pain are not actually having a heart attack, making an emergency hospital visit unnecessary. Is there a way to quickly and accurately determine at home whether emergency hospital treatment is necessary?

read more

Radboud university medical center treats metastatic liver cancer with holmium microspheres MRI imaging during surgery can improve the outcome

4 January 2019

For the first time Radboud university medical center has treated a patient with liver metastases by using holmium radio-embolization. With this technique, radioactive holmium microspheres are injected via a catheter into the liver artery.

read more

Research into drugs for treating rare diseases can be more efficient and patient-oriented

18 December 2018

To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).

read more